Since 1997, ProRhythm has pioneered the application of HIFU (High Intensity Focused Ultrasound) to advance the minimally invasive treatment of complex medical conditions. In recent years ProRhythm has concentrated its efforts on the development of HIFU for the treatment of Atrial Fibrillation (AF), a debilitating arrhythmia. AF is an uncontrollable, rapid, heartbeat that results in a significant decline in the quality of life and may lead to serious complications. Globally, in excess of 9 million people are afflicted with AF and the current treatment options are expensive, often inadequate and non-curative, as with the case of drug therapy.

ProRhythm’s HIFU Ablation System is currently under investigation in clinical trials in the United States to treat AF. ProRhythm believes that its technology may eventually play a significant role in improving the lives of countless individuals who are afflicted by Atrial Fibrillation.

Further information can be found at www.prorhythm.com